Automating Tissue Macro-Dissection with Insight
1 October 2026 | Learn how NCI teamed up with Indica Labs and Xyall to develop an end-to-end solution for automating tissue macro-dissection
Automating Tissue Macro-Dissection with Insight Read More »
HALO Macrodissection Solutions
HALO Macrodissection Solutions Brochure
Learn more about the automated workflow and benefits of HALO Macrodissection Solutions
HALO Macrodissection Solutions Brochure Read More »
Indica Labs Sets New Standard for Molecular Testing in Breast Cancer with Expansion of AI Macrodissection Portfolio
Albuquerque, NM, February 10, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the expansion of its macrodissection portfolio with the launch of Breast Macrodissect AI . The suite now includes advanced algorithms for non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and breast cancer, with prostate cancer planned for release in early 2026.
HALO Clinical AI Flyer
Check out our flyer to learn more about HALO Clinical AI Solutions
HALO Clinical AI Flyer Read More »
Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI
Albuquerque, NM, April 17, 2025 – Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today the expansion of their macrodissection suite with the launch of CRC Macrodissect AI. This expanded portfolio of AI powered tools by Indica Labs will facilitate a macrodissection workflow that minimizes human error and improves efficiency across multiple disease sites. Utilizing the integrative power of artificial intelligence and digital pathology, CRC Macrodissect AI will advance the field of molecular pathology and offer unparalleled insight into colorectal carcinoma.
Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI Read More »
Indica Labs Announces Launch of AI-Powered Macrodissection Suite to Advance Molecular Pathology Workflows
Albuquerque, NM – 1 August 2024 – Indica Labs, the leading provider of AI-powered digital pathology solutions, proudly announces the launch of Lung Macrodissect AI, a groundbreaking tool that revolutionizes slide macrodissection and molecular pathology workflows.